Abeona Therapeutics Inc. (ABEO) Financials

ABEO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 64.0 million 49.2 million
2023-09-30 66.1 million 44.0 million
2023-06-30 53.6 million 44.2 million
2023-03-31 53.3 million 34.6 million

ABEO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -9.3 million 1.5 million
2023-09-30 -5.8 million 1.6 million
2023-06-30 -10.3 million 927000
2023-03-31 -12.0 million 770000

ABEO Net Income

No data available :(

ABEO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 52.6 million - 5.4 million
2023-09-30 53.8 million - 5.7 million
2023-06-30 36.8 million - 6.0 million
2023-03-31 40.4 million - 7.3 million

ABEO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 25.6 million
2023-09-30 24.8 million
2023-06-30 18.0 million
2023-03-31 16.9 million

ABEO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 37000 7.4 million 5.8 million -
2023-09-30 44000 7.1 million 4.2 million -
2023-06-30 32000 8.5 million 5.0 million -
2023-03-31 218000 8.0 million 4.0 million -

ABEO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 721000
2023-09-30 - 751000
2023-06-30 3.5 million 838000
2023-03-31 - 888000

ABEO

Price: $4.60

52 week price:
2.73
9.01

Earnings Per Share: -2.53 USD

P/E Ratio: -3.23

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 254600

Ebitda: -5.2 million

Market Capitalization: 203.5 million

Links: